Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 16, 2018
Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
AUSTIN, Texas, May 16, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
May 15, 2018
Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
CRANBURY, N.J., May 15, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
May 15, 2018
BioCanCell Reports First Quarter 2018 Financial and Operational Results and Provides Corporate Update
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (BICL.TA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies ...
May 15, 2018
UroGen Pharma Reports First Quarter 2018 Financial Results and Recent Corporate Developments
RA’ANANA, Israel, and NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 15, 2018
Aimmune Therapeutics to Present Data on Peanut Allergy at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it will present data on peanut ...
May 15, 2018
Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and ...
May 15, 2018
Aeglea BioTherapeutics to Present at UBS Global Healthcare Conference
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
May 15, 2018
Lysogene Announces the Nomination of Dr Ralph Laufer as Chief Scientific Officer and Member of the Executive Team
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Lysogene (LYS.PA) (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, is pleased ...
May 15, 2018
INVENTIVA : First-quarter 2018 financial update
Daix (France), May 15, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
May 15, 2018
Bulletin from Moberg Pharma's AGM 2018
STOCKHOLM, May 15, 2018 /PRNewswire/ -- Moberg Pharma AB's ("Company") Annual General Meeting took place on Tuesday, May 15th, 2018 in the Company´s premises in Bromma. ...
May 15, 2018
BIOPHYTIS Receives Orphan Drug Designation in the United States for Sarconeos in Duchenne Muscular Dystrophy (DMD)
PARIS, May 15, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related degenerative ...
May 15, 2018
Altimmune Announces First Quarter 2018 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three months ended March ...
May 15, 2018
Aileron Therapeutics Announces Changes to Management
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other ...
May 15, 2018
Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 15, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
May 15, 2018
Oncobiologics Reports Second Quarter Financial Results for Fiscal 2018
CRANBURY, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today reported financial results and business highlights for its three and six months ended ...
May 15, 2018
Molecular Templates to Present at the UBS Global Healthcare Conference
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the ...
May 15, 2018
AIT Therapeutics to Present Data from Its Inhaled Nitric Oxide Study in Patients Infected with Mycobacterium Abscessus Complex at the 2018 American Thoracic Society Conference
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
May 15, 2018
Celyad announces launch of proposed global offering
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 15, 2018
Celyad Announces First Quarter 2018 Business Update
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 14, 2018
ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest
RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today that it has ...
Page 51 of 128